IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | 280.30K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.90K | 4.80K | 17.40K | 39.00K | 62.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.10K | 2.50K | 6.30K |
| Total Current Assets | 44.90K | 4.80K | 18.60K | 41.50K | 348.70K |
|
|
|||||
| Total Current Assets | 44.90K | 4.80K | 18.60K | 41.50K | 348.70K |
| Net Property, Plant & Equipment | 20.90K | 22.70K | 24.70K | 26.80K | 29.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 7.70K | 7.70K |
| Total Assets | 65.80K | 27.50K | 43.30K | 76.00K | 385.50K |
|
|
|||||
| Total Accounts Payable | 2.30M | 1.93M | 1.63M | 1.09M | 751.00K |
| Total Accrued Expenses | 230.90K | 109.40K | 3.20K | 3.20K | 3.20K |
| Short-term Debt | 55.20K | 59.80K | 43.70K | 21.00K | 28.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.61M | -- | 3.00M | 2.00M | 2.00M |
| Total Finance Division Other Current Liabilities | 303.20K | 303.20K | 485.10K | 303.20K | 303.20K |
| Total Other Current Liabilities | 303.20K | 303.20K | 485.10K | 303.20K | 303.20K |
| Total Current Liabilities | 6.51M | 2.41M | 5.16M | 3.41M | 3.09M |
|
|
|||||
| Total Current Liabilities | 6.51M | 2.41M | 5.16M | 3.41M | 3.09M |
| Long-Term Debt | -- | 3.10M | 3.75M | 4.35M | 4.06M |
| Short-term Debt | 55.20K | 59.80K | 43.70K | 21.00K | 28.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 895.20K | 1.68M | 1.40M | 4.40M | 2.26M |
| Total Liabilities | 7.40M | 7.19M | 10.31M | 12.16M | 9.40M |
|
|
|||||
| Common Stock & APIC | 19.73M | 19.61M | 19.64M | 18.98M | 18.73M |
| Retained Earnings | -33.04M | -32.69M | -29.90M | -31.09M | -27.76M |
| Treasury Stock & Other | -- | -- | -- | 20.40K | 10.20K |
| Total Common Equity | -13.31M | -13.08M | -10.27M | -12.08M | -9.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.97M | 5.92M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.97M | 5.92M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.31M | -13.08M | -10.27M | -12.08M | -9.02M |
| Total Preferred Equity | 5.97M | 5.92M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.34M | -7.16M | -10.27M | -12.08M | -9.02M |
|
|
|||||